GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
7JMP | 7JMP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 | |
7JMW | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab | |
7JMW | 7JMW | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab | |
7JN5 | Q19QX0 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 | |
7JN5 | 7JN5 | Crystal structure of SARS-CoV receptor binding domain in complex with human antibody CR3022 | |
7JNA | Q9H813 | Cryo-EM structure of human proton-activated chloride channel PAC at pH 8 | |
7JNB | A0A0H2YN38 | The structure of CBM32-1 and CBM32-2 domains from Clostridium perfringens ZmpB in complex with GalNAc | |
7JNC | Q9H813 | cryo-EM structure of human proton-activated chloride channel PAC at pH 4 | |
7JNF | A0A0H2YN38 | The structure of CBM32-1 and CBM32-2 domains from Clostridium perfringens ZmpB in complex with GalNAc | |
7JOO | Q9Y6W8 | Crystal structure of ICOS in complex with antibody STIM003 and anti-kappa VHH domain | |
7JOO | 7JOO | Crystal structure of ICOS in complex with antibody STIM003 and anti-kappa VHH domain | |
7JPD | Q20MG8 | Crystal structure of the trimeric full length mature hemagglutinin from influenza A virus A/Fort Monmouth/1/1947 | |
7JPH | 7JPH | Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution | |
7JPH | Q05320 | Crystal structure of EBOV glycoprotein with modified HR1c and HR2 stalk at 3.2 A resolution | |
7JPI | 7JPI | Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution | |
7JPI | Q05320 | Crystal structure of EBOV glycoprotein with modified HR2 stalk at 2.3A resolution | |
7JPT | O60449 | Structure of an endocytic receptor | |
7JRL | A0A0H2YN38 | The structure of CBM51-2 in complex with GlcNAc and INT domains from Clostridium perfringens ZmpB | |
7JSJ | Q86YT5 | Structure of the NaCT-PF2 complex | |
7JSK | Q86YT5 | Structure of the NaCT-Citrate complex | |
7JTG | 7JTG | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody RM11-43 | |
7JTG | B9V0E2 | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody RM11-43 | |
7JTR | P0AEX9 | Complex of maltose-binding protein (MBP) with single-chain Fv (scFv) | |
7JTR | 7JTR | Complex of maltose-binding protein (MBP) with single-chain Fv (scFv) | |
7JTV | Q9I5W4 | Structure of IMPa from Pseudomonas aeruginosa in complex with an O-glycopeptide | |
7JTV | 7JTV | Structure of IMPa from Pseudomonas aeruginosa in complex with an O-glycopeptide | |
7JUB | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with methyl-mannoside | |
7JUC | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with methyl-mannoside | |
7JUD | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with methyl-mannoside | |
7JUE | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Man-alpha1-2Man | |
7JUF | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Man-alpha1-2Man | |
7JUG | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Man-alpha1-6Man | |
7JUH | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Man-alpha1-6Man | |
7JV4 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) | |
7JV4 | 7JV4 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (one RBD open) | |
7JV6 | P0DTC2 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | |
7JV6 | 7JV6 | SARS-CoV-2 spike in complex with the S2H13 neutralizing antibody (closed conformation) | |
7JV9 | P21589 | Human CD73 (ecto 5'-nucleotidase) in complex with compound 12 | |
7JVA | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | |
7JVA | 7JVA | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains) | |
7JVC | P0DTC2 | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | |
7JVC | 7JVC | SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment | |
7JVD | 7JVD | Fab of 5.6 monoclonal mouse IgG1 co-crystallized with the trisaccharide form of serotype 3 pneumococcal capsular polysaccharide | |
7JW0 | P0DTC2 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | |
7JW0 | 7JW0 | SARS-CoV-2 spike in complex with the S304 neutralizing antibody Fab fragment | |
7JW4 | 7JW4 | Crystal structure of PdGH110B in complex with D-galactose | |
7JWF | 7JWF | Crystal structure of PdGH110B D344N in complex with alpha-(1,3)-galactobiose | |
7JWY | P0DTC2 | Structure of SARS-CoV-2 spike at pH 4.5 | |
7JX3 | 7JX3 | Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology | |
7JX3 | P0DTC2 | Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024